(S (NP (PRP We)) (VP (VBP investigate) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (JJ hybrid) (NNS techniques))) (PP (IN in) (NP (NP (JJ complex) (NNS processes)) (PP (IN of) (NP (JJ infectious) (NNS diseases))))))) (. .))
(S (SBAR (IN Since) (S (NP (NP (JJ predictive) (NN disease) (NNS models)) (PP (IN in) (NP (NN biomedicine)))) (VP (VBP require) (NP (DT a) (JJ multiscale) (NN approach)) (PP (IN for) (S (VP (VBG understanding) (NP (DT the) (JJ molecule-cell-tissue-organ-body) (NNS interactions)))))))) (, ,) (NP (JJ heterogeneous) (NNS methodologies)) (VP (VBP are) (ADVP (RB often)) (VP (VBN employed) (PP (IN for) (S (VP (VBG describing) (NP (DT the) (JJ different) (JJ biological) (NNS scales))))))) (. .))
(S (S (NP (NNP Hybrid) (NNS models)) (VP (VBP provide) (NP (NP (JJ effective) (NNS means)) (PP (IN for) (NP (JJ complex) (NN disease) (VBG modelling))) (SBAR (WHADVP (WRB where)) (S (NP (NP (DT the) (NN action) (CC and) (NN dosage)) (PP (IN of) (NP (NP (DT a) (NN drug)) (CC or) (NP (DT a) (NN therapy))))) (VP (MD could) (VP (VB be) (VP (ADVP (RB meaningfully)) (VP (VBN investigated)))))))))) (: :) (S (NP (DT the) (NN infection) (NNS dynamics)) (VP (MD can) (VP (VB be) (VP (ADVP (RB classically)) (VBN described) (PP (IN in) (NP (DT a) (JJ continuous) (NN fashion))) (, ,) (SBAR (IN while) (S (NP (NP (DT the) (NN scheduling)) (PP (IN of) (NP (JJ multiple) (NN treatment)))) (ADVP (RB discretely)))))))) (. .))
(S (NP (PRP We)) (VP (VBP define) (NP (NP (DT an) (JJ algebraic) (NN language)) (PP (IN for) (S (VP (VBG specifying) (NP (NP (JJ general) (NN disease) (NNS processes)) (CC and) (NP (JJ multiple) (NNS treatments)))))) (, ,) (SBAR (WHPP (IN from) (WHNP (WDT which))) (S (NP (NP (DT a) (NNS semantics)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (JJ hybrid) (JJ dynamical) (NN system)))))) (VP (MD can) (VP (VB be) (VP (VBN derived)))))))) (. .))
(S (ADVP (RB Then)) (, ,) (NP (NP (DT the) (NN application)) (PP (IN of) (NP (JJ control-theoretic) (NNS tools)))) (VP (VBZ is) (VP (VBN proposed) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB compute) (NP (NP (DT the) (JJ optimal) (NN scheduling)) (PP (IN of) (NP (JJ multiple) (NNS therapies)))))))))) (. .))
(S (S (NP (NP (DT The) (NNS potentialities)) (PP (IN of) (NP (PRP$ our) (NN approach)))) (VP (VBP are) (VP (VBN shown) (PP (IN in) (NP (NP (DT the) (NN case) (NN study)) (PP (IN of) (NP (DT the) (NNP SIR) (JJ epidemic) (NN model)))))))) (CC and) (S (NP (PRP we)) (VP (VBP discuss) (NP (NP (PRP$ its) (NN applicability)) (PP (IN on) (NP (NP (NN osteomyelitis)) (, ,) (NP (NP (DT a) (JJ bacterial) (NN infection)) (VP (VBG affecting) (NP (DT the) (NN bone) (VBG remodelling) (NN system)) (PP (IN in) (NP (DT a) (ADJP (NN specific) (CC and) (JJ multiscale)) (NN manner)))))))))) (. .))
(S (NP (PRP We)) (VP (VBP report) (SBAR (SBAR (IN that) (S (NP (JJ formal) (NNS languages)) (VP (VBP are) (ADJP (JJ helpful) (PP (IN in) (S (VP (VBG giving) (NP (NP (DT a) (JJ general) (JJ homogeneous) (NN formulation)) (PP (IN for) (NP (NP (DT the) (JJ different) (NNS scales)) (VP (VBN involved) (PP (IN in) (NP (DT a) (JJ multiscale) (NN disease) (NN process)))))))))))))) (: ;) (CC and) (SBAR (IN that) (S (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (NP (JJ hybrid) (NN modelling)) (CC and) (NP (NN control) (NN theory))))) (VP (VBZ provides) (NP (NP (JJ solid) (NNS grounds)) (PP (IN for) (NP (JJ computational) (NN medicine))))))))) (. .))
